⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Aircraft Ground Support Equipment Market to Hit USD 19.7 Billion by 2035 as Smart Airport Investments and Electrification Accelerate
prnewswire.com
TT
HON
GE
BA
GD
LMT
RTX
AVAV
ALGN
AMZN
GOOG
MSFT
IBM
SAP
ORCL
INTC
NVDA
AMD
QCOM
MU
AMAT
LRCX
KLAC
ADI
TXN
MCHP
NXPI
ON
INFY
DXC
CTAS
PAYX
ADP
ACN
VRSN
CDNS
SNPS
MRVL
ADSK
PTC
NOW
CRM
PANW
FTNT
ZBRA
SMCI
DELL
HPQ
LEN
DHI
NVR
TOL
PHM
KBH
BBY
HD
LOW
TJX
MDT
AMGN
GILD
BMY
PFE
JNJ
MRK
ABBV
LLY
AZN
NVS
XOM
CVX
SHEL
TTE
COP
MPC
VLO
PBF
EOG
APA
OXY
KMI
ET
BHP
RIO
VALE
NEM
FCX
AA
CLF
STLD
CF
MOS
NTR
DD
DOW
LIN
APD
EMR
MMM
CAT
DE
AGCO
CNH
EPRI Launches Flex MOSAIC to Reduce ‘Time to Power’ for Data Centers
globenewswire.com
GOOGL
NVDA
EXC
DTE
LNT
SO
PCG
EIX
PNW
ETR
PPL
SRE
CMS
NI
AEP
XEL
LUV
HON
SI
LIN
PEG
ECL
FE
WEC
NRG
ED
ES
MDU
NE
UTL
CWEN
BEP
TER
MAS
AMAT
MU
INTC
AMD
CDNS
SNPS
VRTX
GILD
AMGN
BIIB
REGN
AZN
NVS
PFE
MRK
JNJ
ABBV
BMY
LLY
TEVA
BCE
CVE
CP
RY
TD
BNS
CM
CNQ
SU
BHP
RIO
VAL
FCX
AA
STLD
CF
MOS
NTR
ADM
BG
CARR
EMR
GOOG
META
S
VZ
T
TMUS
CCI
AMT
EQIX
DLR
IBM
MSFT
AMZN
CSCO
LRCX
KLAC
ADI
TXN
ON
NXPI
INFY
CTSH
ACN
Breckenridge announces launch of Milnacipran HCl Tablets, generic equivalent of Savella®
prnewswire.com
ABBV
Allergan Aesthetics Reveals Evolution in Approach to Modern Aesthetic Treatments with Comprehensive Global Survey and New Educational Solutions
prnewswire.com
ABBV
Semafor Unveils 450 Top Global CEOs and Government Leaders for Semafor World Economy 2026
prnewswire.com
HON
LLY
LAZ
QCOM
GS
BAH
BKR
PNC
ALL
MET
EXPE
JLL
MSFT
GOOG
NVDA
META
CRWD
VZ
BEN
CAVA
IBM
AMZN
INTC
AMD
CSCO
PANW
ETSY
UBER
LYFT
GE
USFD
SBUX
MCD
YUM
CVS
MRNA
PFE
JNJ
ABBV
BMY
GILD
REGN
AMGN
BIIB
VRTX
AZN
NVO
LULU
URBN
RL
MAT
UAA
INFY
ARM
ISRG
TDOC
TAP
FSLR
NEE
BE
PLUG
FCEL
RUN
SEDG
ENPH
ALNY
CRSP
EDIT
NTLA
ACLS
EXAS
ASO
ATHM
COIN
PYPL
MPWR
ON
AMAT
LRCX
KLAC
ASML
ADI
NXPI
TXN
WIT
HPE
OKTA
FTNT
DDOG
SNOW
PLTR
SPCE
RBLX
Genmab Showcases Data From Comprehensive Epcoritamab Development Program in Patients Across B-Cell Lymphomas at European Hematology Association (EHA) Annual Meeting 2023
globenewswire.com
GMAB
ABBV
Genmab Announces Epcoritamab Added to National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for ‘B-Cell Lymphomas’
globenewswire.com
GMAB
ABBV
New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)
globenewswire.com
GMAB
ABBV
U.S. FDA Accepts for Priority Review the Supplemental Biologics License Application for Epcoritamab (EPKINLY®) for Difficult-to-Treat Relapsed or Refractory Follicular Lymphoma
globenewswire.com
GMAB
ABBV
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
globenewswire.com
GMAB
ABBV
PFE